Q2 2017 and investor event
We announced our second quarter 2017 results today and hosted an investor event where Emma Walmsley, CEO, and Simon Dingemans, CFO, spoke about our strategic priorities and financial outlook.
Q2 2017 downloads
- Q2 2017 results announcement PDF - 1.9MB
- Q2 2017 results video transcript PDF - 177.6KB
- Q2 2017 US dollar translation PDF - 121.7KB
- Q2 2017 results infographic PDF - 862.6KB
- Q2 2017 pre announcement aide memoire PDF - 795.1KB
- Emma Walmsley slides: Key priorities PDF - 864.3KB
- Simon Dingemans slides: Q2 and financial outlook PDF - 159.5KB
2015 First Quarter and prospects for newly shaped Group
Watch Simon Dingemans, CFO, discuss our first quarter results 2015.
2014 Fourth Quarter
Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our full year 2014 results.
2014 Third Quarter
Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our third quarter 2014 results.
- Q3 2014 results announcement PDF - 698.0KB
- Q3 2014 analyst webcast transcript PDF - 218.1KB
- Q3 2014 launch metrics and pipeline progress PDF - 150.2KB
- Q3 2014 restated finanical Information XLSX - 51.2KB
- Q3 2014 actual growth schedules PDF - 163.4KB
- Q3 2014 US dollar translation PDF - 143.8KB
- Q3 2014 pre announcement aide memoire PDF - 980.8KB
2014 Second Quarter
Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our second quarter 2014 results.
Other key information
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Keep up to date with our news and recent announcements
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III